IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...
To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...
The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...
Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...
Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...
HealthDay on MSN4d
Medicare to Negotiate Prices for 15 More Drugs, Including OzempicMedicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.
The Inflation Reduction Act of 2022 has triggered a raft of changes to Medicare Part D plans and Medicare Advantage plans that affect prescription drug coverage in 2025. Here’s what to know.
Makers of drugs and medical devices say the tariffs on goods from Canada, Mexico and China could have an outsized impact on ...
Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...
President Biden's time in office has finally expired. But his signature legislative accomplishment—the Inflation Reduction ...
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback